Showing results (171-180 of 315) with videos related to

Sort By:
Pageof 32
Blood|November 26, 2010
Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observationMauricette Michallet, Peter Dreger, Laurent Sutton, et al.
Leukemia & Lymphoma|May 2, 2013
Second-line therapies of patients initially treated with fludarabine and cyclophosphamide or fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia within the CLL8 protocol of the German CLL Study GroupPaula Cramer, Anna-Maria Fink, Raymonde Busch, et al.
Leukemia & Lymphoma|October 12, 2020
Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia - a study of the Acute Leukemia Working Party of the EBMTThomas Heinicke, Myriam Labopin, Emmanuelle Polge, et al.
Transplantation and Cellular Therapy|September 14, 2023
Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma: A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation AnalysisPatrick Derigs, Wolfgang A Bethge, Isabelle Krämer, et al.
American Journal of Hematology|October 4, 2017
High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working partySaad Akhtar, Silvia Montoto, Ariane Boumendil, et al.
Frontiers in Immunology|December 28, 2020
Pre-sensitization of Malignant B Cells Through Venetoclax Significantly Improves the Cytotoxic Efficacy of CD19.CAR-T CellsMingya Yang, Lei Wang, Ming Ni, et al.
Frontiers in Immunology|June 14, 2021
Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell ImmunotherapyMingya Yang, Lei Wang, Ming Ni, et al.
Blood Cancer Journal|March 15, 2024
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantationOlaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Ebiomedicine|February 5, 2016
Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort StudyAlois Gratwohl, Anna Sureda, Helen Baldomero, et al.
Bone Marrow Transplantation|February 21, 2024
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparisonDietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, et al.
Pageof 32